Delivery of antiviral agents in liposomes
- PMID: 15721391
- DOI: 10.1016/S0076-6879(05)91020-3
Delivery of antiviral agents in liposomes
Abstract
The intracellular activity of certain antiviral agents, including antisense oligonucleotides, acyclic nucleoside phosphonates, and protease inhibitors, is enhanced when they are delivered in liposome-encapsulated form. In this chapter we describe the preparation of pH-sensitive liposomes encapsulating antisense oligonucleotides, ribozymes, and acyclic nucleoside phosphonate analogues and their effects on HIV replication in macrophages. We outline the use of liposomal HIV protease inhibitors in infected macrophages. We present two methods for the covalent coupling of soluble CD4 to liposomes and show the association of these liposomes with HIV-infected cells. We also describe the synthesis of a novel antiviral agent based on cyclodextrin and its incorporation into liposomes.
Similar articles
-
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.Antiviral Res. 2009 Nov;84(2):142-9. doi: 10.1016/j.antiviral.2009.08.003. Epub 2009 Aug 20. Antiviral Res. 2009. PMID: 19699239
-
Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):515-23. doi: 10.1081/NCN-100002327. Nucleosides Nucleotides Nucleic Acids. 2001. PMID: 11563068
-
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.Mol Membr Biol. 1999 Jan-Mar;16(1):111-8. doi: 10.1080/096876899294832. Mol Membr Biol. 1999. PMID: 10332745 Review.
-
"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.Adv Drug Deliv Rev. 2004 Apr 23;56(7):931-46. doi: 10.1016/j.addr.2003.10.037. Adv Drug Deliv Rev. 2004. PMID: 15066753 Review.
-
Entrapment of small molecules and nucleic acid-based drugs in liposomes.Methods Enzymol. 2005;391:7-40. doi: 10.1016/S0076-6879(05)91001-X. Methods Enzymol. 2005. PMID: 15721372
Cited by
-
Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.Expert Opin Drug Deliv. 2009 Apr;6(4):405-20. doi: 10.1517/17425240902824808. Expert Opin Drug Deliv. 2009. PMID: 19382883 Free PMC article. Review.
-
Novel approaches for COVID-19 diagnosis and treatment: a nonsystematic review.Turk J Biol. 2021 Aug 30;45(4):358-371. doi: 10.3906/biy-2105-45. eCollection 2021. Turk J Biol. 2021. PMID: 34803440 Free PMC article. Review.
-
Polymeric nanogel formulations of nucleoside analogs.Expert Opin Drug Deliv. 2007 Jan;4(1):5-17. doi: 10.1517/17425247.4.1.5. Expert Opin Drug Deliv. 2007. PMID: 17184158 Free PMC article. Review.
-
Novel anticancer polymeric conjugates of activated nucleoside analogues.Bioconjug Chem. 2011 Oct 19;22(10):1983-93. doi: 10.1021/bc200173e. Epub 2011 Sep 9. Bioconjug Chem. 2011. PMID: 21863885 Free PMC article.
-
Therapeutic Potential of Antiviral Peptides against the NS2B/NS3 Protease of Zika Virus.ACS Omega. 2023 Sep 13;8(38):35207-35218. doi: 10.1021/acsomega.3c04903. eCollection 2023 Sep 26. ACS Omega. 2023. PMID: 37779969 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials